These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11358679)

  • 1. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes.
    Fried LF; Forrest KY; Ellis D; Chang Y; Silvers N; Orchard TJ
    J Diabetes Complications; 2001; 15(3):113-9. PubMed ID: 11358679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
    J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
    Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
    Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
    Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
    Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia.
    Sen K; Misra A; Kumar A; Pandey RM
    Diabetes Res Clin Pract; 2002 Apr; 56(1):1-11. PubMed ID: 11879715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE
    Diabetologia; 1993 Oct; 36(10):1079-86. PubMed ID: 8243858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW; Estacio RO; Esler A; Mehler P
    Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
    Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
    Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy.
    Lam KS; Cheng IK; Janus ED; Pang RW
    Diabetologia; 1995 May; 38(5):604-9. PubMed ID: 7489845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of simvastatin on insulin sensitivity in Type 2 diabetic patients with hypercholesterolaemia: results from a double-blind, randomized, placebo-controlled crossover study.
    Hwu CM; Kwok CF; Chen HS; Shih KC; Lee SH; Hsiao LC; Lin SH; Ho LT
    Diabet Med; 1999 Sep; 16(9):749-54. PubMed ID: 10510951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil in diabetic nephropathy.
    Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
    Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.